Ferguson Wellman Capital Management, Inc Gilead Sciences, Inc. Transaction History
Ferguson Wellman Capital Management, Inc
- $5.07 Billion
- Q4 2024
A detailed history of Ferguson Wellman Capital Management, Inc transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Ferguson Wellman Capital Management, Inc holds 4,140 shares of GILD stock, worth $438,674. This represents 0.01% of its overall portfolio holdings.
Number of Shares
4,140
Previous 4,994
17.1%
Holding current value
$438,674
Previous $418,000
8.61%
% of portfolio
0.01%
Previous 0.01%
Shares
30 transactions
Others Institutions Holding GILD
# of Institutions
2,045Shares Held
1BCall Options Held
10MPut Options Held
9.05M-
Black Rock Inc. New York, NY121MShares$12.8 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA116MShares$12.2 Billion0.19% of portfolio
-
Capital World Investors Los Angeles, CA71.7MShares$7.6 Billion1.05% of portfolio
-
State Street Corp Boston, MA60.2MShares$6.38 Billion0.21% of portfolio
-
Capital Research Global Investors Los Angeles, CA57.9MShares$6.14 Billion1.15% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $133B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...